Drug Profile
Research programme: autoimmune disease therapeutics and diagnostics - Nodality/Pfizer
Latest Information Update: 28 Dec 2018
Price :
$50
*
At a glance
- Originator Nodality; Pfizer
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for research development in Autoimmune-disorders(Diagnosis) in USA
- 28 Jul 2018 No recent reports of development identified for research development in Autoimmune-disorders in USA
- 17 Apr 2013 Early research is ongoing in USA